All Access Articles |
- Ionis Pharmaceuticals Reports $705M Revenue for 2024 | 2025-02-19 | PHARMACEUTICAL
- Why Does Ionis Pharmaceuticals (IONS) Have a Good Analyst Rating? | 2024-06-24 | PHARMACEUTICAL
- Ionis Pharmaceuticals Expands Licensing Agreement with Otsuka for Hereditary Angioedema Treatment | 2024-06-18 | PHARMACEUTICAL
- What Are the Tailwinds for IONS? | 2023-04-18 | PHARMACEUTICAL